Circulating tumor DNA predicts recurrence and splits disease into two subgroups of Hodgkin lymphoma. New drug targets or changes in treatments may reduce toxicity.
Read more https://www.sciencedaily.com/releases/2023/12/231211114516.htm
Circulating tumor DNA predicts recurrence and splits disease into two subgroups of Hodgkin lymphoma. New drug targets or changes in treatments may reduce toxicity.
Read more https://www.sciencedaily.com/releases/2023/12/231211114516.htm